Alternative Medicine

Amino Acids

Arthralgia

Autism

Autoimmune Disease

Cell Danger Response

Chronic Fatigue Syndrome

Chronic Inflammatory Disease

Disease Diagnosis

End Products

Metabolomics, the Cell Danger Response, and Peptide Therapy

Peptide - December 2020

Peptide Relaunch - March 2021

Peptide Summit Relaunch - December 2021

<h6>Kent Holtorf, M.D.</h6>
Hello, it's dr. Kent hold tour with another episode for the peptide summit. And today we'll be talking with dr. Eric Gordon. Um, these are talk about, uh, minimal omics mitochondria cell danger response, new way of looking at these chronic illnesses and, uh, you know, how they re relate to health and how peptides can be used to kind of fit into the picture, but really looking at different way of looking at chronic illness. And I think you really, uh, enjoy this and I've known Eric for a long time and him a great friend and see him at almost every conference and, uh, AIDS he's been around he's, um, president of the Gordon medical research center and founder owner quartered, a medical associates, a private medical practice in San Francisco Bay area, specializing in complex chronic illness. In addition to his clinical practice over 40 years. Hey, he doesn't look over 30 to me though, but, uh, he's engaged in a lot of clinical research.

https://drsummits.s3.us-west-1.amazonaws.com/Peptide+Summit/Transcript/Dr.-Eric-Gordon-New-Transcript.pdf

Eric Gordon, MD is President of Gordon Medical Research Center and clinical director of Gordon Medical Associates which specializes in complex chronic illness. In addition to being in clinical practice for over 40 years, Dr. Gordon is engaged in clinical research focused on bringing together leading international medical researchers and cutting-edge clinicians. His research is focusing on ME/CFS, Lyme disease, autoimmune diseases, and autism.

Eric Gordon

Eric Gordon, MD

Kent Holtorf, MD is the medical director of the Holtorf Medical Group (www.HoltorfMed.com) and the founder and medical director of the non-profit National Academy of Hypothyroidism (NAH) (www.NAHypothyroidism.org), which is dedicated to the dissemination of new information to doctors and patients on the diagnosis and treatment of hypothyroidism. He is also the founder of Integrative Peptides (IntegrativePeptides.com), which is dedicated to the training of physicians regarding ground-breaking peptide therapies for their patients and bringing the highest quality peptides via supplement and unique delivery forms to doctors and patients, having the first and only BPC-157 in supplement version.

Kent Holtorf, MD

Metabolomics, the Cell Danger Response, and Peptide Therapy

Kent Holtorf, MD

Eric Gordon, MD

Summary

Content Provided By

Kent Holtorf, MD

Guest Experts

Eric Gordon, MD